论文部分内容阅读
目的：分析研讨低分子肝素钙对不稳定型心绞痛（UAP）的临床疗效，以及治疗安全性。方法采用随机抽签方式，从我院2014年1月至2016年2月期间收治的不稳定型心绞痛患者中，抽取220例纳入到研讨领域中，220例依据入院顺序分两组，110例对照组，110例研究组，对照组接受常规性治疗，研究组接受低分子肝素钙治疗，把治疗状况列入到对比讨论中。结果研究组治疗总疗效91．82％比对照组80．91％明显要高，组间数据有统计学意义（P＜0．05）。研究组并发症总发生8．18％比对照组25．45％明显要低，组间数据有统计学意义（P＜0．05）。结论临床在治疗不稳定型心绞痛疾病时可考虑给予低分子肝素钙，疗效突出，操作简单，安全，推广应用价值高。“,”Objective to analyze the clinical ef ect of low molecular weight heparin calcium on unstable angina pectoris(UAP),and to discuss the safety and ef icacy of the treatment. Methods by random draw,from admit ed in our hospital from January 2014 to 2016 2 month period of unstable angina patients,extraction of 220 cases of into the research field,220 cases ac-cording to the order of admission were divided into two groups,110 cases of control group,110 cases of study group,control group received routine treatment,study group received low molecular weight heparin calcium in the treatment,the treatment included in the comparison discussion.Results the total curative efect of the study group was 91.82% higher than that of the control group(80.91%),and the data between the groups was statistical y significant(P<0.05).The incidence of complications in the study group was 8.18% lower than that in the control group (25.45%),and the data were statistical y significant(P<0.05).Conclusion the clinical application of low molecular weight heparin calcium in the treatment of unstable angina can be con-sidered,the ef ect is outstanding,the operation is simple,safe,and the value of popularization and application is high.